Ubs Asset Management Americas Inc Ocular Therapeutix, Inc Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 212,952 shares of OCUL stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,952
Previous 218,588
2.58%
Holding current value
$2.5 Million
Previous $1.87 Million
16.4%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding OCUL
# of Institutions
204Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$168 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$163 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$150 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$135 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.36MShares$98.3 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $904M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...